Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease

NCT02560753 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

T3D Therapeutics, Inc.